Presentation is loading. Please wait.

Presentation is loading. Please wait.

In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding  Takenori Yokota, MD, Hajime Ichikawa,

Published byKjell Jansson Modified over 5 years ago

Similar presentations

Presentation on theme: "In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding  Takenori Yokota, MD, Hajime Ichikawa,"— Presentation transcript:

1 In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding  Takenori Yokota, MD, Hajime Ichikawa, MD, PhD, Goro Matsumiya, MD, PhD, Toru Kuratani, MD, PhD, Taichi Sakaguchi, MD, PhD, Shigemitsu Iwai, MD, PhD, Yukitoshi Shirakawa, MD, PhD, Kei Torikai, MD, PhD, Atsuhiro Saito, PhD, Eiichiro Uchimura, PhD, Naomasa Kawaguchi, PhD, Nariaki Matsuura, MD, PhD, Yoshiki Sawa, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 136, Issue 4, Pages (October 2008) DOI: /j.jtcvs Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 The newly designed small-diameter vascular graft (A, B) was fabricated using a biodegradable woven polymer tube constructed in a plain weave pattern using a double-layered thread with PLLA fibers as the core and PGA fibers as the sheath. Scanning electron micrograph of the double-layered thread (C). The graft surface shows the porous 3-dimensional structure (D) and interconnected pore structure after incorporation of the collagen microsponge (E) (magnification, 100×). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 The number of cells of NIH3T3 (A) and human umbilical vascular endothelial cells (B) cultured for 3 days in vitro on TEVGs with/without the collagen microsponge. Scanning electron micrographs of the same samples with NIH3T3 (C) and human umbilical vascular endothelial cells (D) cultured for 3 days in vitro. HUVEC, Human umbilical vascular endothelial cell. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Macroscopic appearance of TEVGs 2 (A), 4 (B), 6 (C), and 12 (D) months after implantation and of the ePTFE graft 12 months after implantation (E). The scale bar represents 10 mm. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

5 Figure 4 Scanning electron micrograph of the luminal surfaces of TEVGs 2 (A), 4 (B), 6 (C), and 12 (D) months after implantation, compared with that of the ePTFE graft 12 months after implantation (E) (magnification, 500×). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

6 Figure 5 Double staining with hematoxylin-eosin and Victoria blue stain (A), immunohistochemical double staining with von Willebrand factor and α-smooth muscle actin (B), and elastica van Gieson (C) of the PGA/PLLA tube graft 2, 4, 6, and 12 months after implantation, and those of the ePTFE graft 12 months after implantation. The scale bar represents 100 μm. H&E, Hematoxylin-eosin; vWF, von Willebrand factor; SMA, smooth muscle actin; EVG, elastica van Gieson; ePTFE, expanded polytetrafluoroethylene. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

7 Figure 6 The regenerated neointimal and medial wall thickness of the proximal, middle, and distal portions of TEVGs 2, 4, 6, and 12 months after implantation. Error bars indicate standard deviation. The wall thickness increased significantly over time from 2 to 6 months (∗P < .05). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

8 Figure 7 Biochemical analysis of collagen content in the neotissue of TEVGs 2, 4, 6, and 12 months after implantation and that of the native carotid artery (∗P < .05). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

9 Figure 8 Biomechanical analysis showing tensile modulus and tensile strength of TEVGs at preimplantation stage and 2, 4, 6, and 12 months after implantation, and those of the native carotid artery (∗P < .05). MPa, Megapascal. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding  Takenori Yokota, MD, Hajime Ichikawa,"

Similar presentations

Development and regression of intimal thickening of arterially transplanted autologous vein grafts in dogs  Kazumasa Morinaga, M.D., Hiroshi Eguchi, M.D.,

Development and regression of intimal thickening of arterially transplanted autologous vein grafts in dogs  Kazumasa Morinaga, M.D., Hiroshi Eguchi, M.D.,
Prevention of Postoperative Pericardial Adhesions With a Novel Regenerative Collagen Sheet  Hiroyuki Tsukihara, MD, Shinichi Takamoto, MD, PhD, Kazuo.

Prevention of Postoperative Pericardial Adhesions With a Novel Regenerative Collagen Sheet  Hiroyuki Tsukihara, MD, Shinichi Takamoto, MD, PhD, Kazuo.
Shunya Shindo, M. D. , Atsuhiko Takagi, M. D. , Anthony D

Shunya Shindo, M. D. , Atsuhiko Takagi, M. D. , Anthony D
In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix–like topography  Osamu Ishii, MD, Michael Shin,

In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix–like topography  Osamu Ishii, MD, Michael Shin,
Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 

Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 
Liposuction-derived human fat used for vascular graft sodding contains endothelial cells and not mesothelial cells as the major cell type  Stuart K. Williams,

Liposuction-derived human fat used for vascular graft sodding contains endothelial cells and not mesothelial cells as the major cell type  Stuart K. Williams,
A new staged hybrid total arch repair procedure using a branched proximal elephant trunk technique with implantation of stent grafts to the ascending.

A new staged hybrid total arch repair procedure using a branched proximal elephant trunk technique with implantation of stent grafts to the ascending.
Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Hajime.

Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Hajime.
Tracheal regeneration: Myth or fact?

Tracheal regeneration: Myth or fact?
Reconstruction of pulmonary artery with porcine small intestinal submucosa in a lamb surgical model: Viability and growth potential  Lorenzo Boni, MD,

Reconstruction of pulmonary artery with porcine small intestinal submucosa in a lamb surgical model: Viability and growth potential  Lorenzo Boni, MD,
Mesothelium regeneration on acellular bovine pericardia loaded with an angiogenic agent (ginsenoside Rg1) successfully reduces postsurgical pericardial.

Mesothelium regeneration on acellular bovine pericardia loaded with an angiogenic agent (ginsenoside Rg1) successfully reduces postsurgical pericardial.
Experimental generation of a tissue-engineered functional and vascularized trachea  Thorsten Walles, MD, Bettina Giere, Michael Hofmann, PhD, Johanna Schanz,

Experimental generation of a tissue-engineered functional and vascularized trachea  Thorsten Walles, MD, Bettina Giere, Michael Hofmann, PhD, Johanna Schanz,
Experimental noninferiority trial of synthetic small-caliber biodegradable versus stable vascular grafts  Damiano Mugnai, MD, Jean-Christophe Tille, MD,

Experimental noninferiority trial of synthetic small-caliber biodegradable versus stable vascular grafts  Damiano Mugnai, MD, Jean-Christophe Tille, MD,
A slow-releasing form of prostacyclin agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function.

A slow-releasing form of prostacyclin agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function.
Tracheal regeneration: Evidence of bone marrow mesenchymal stem cell involvement  Agathe Seguin, MD, PhD, Sonia Baccari, MD, Muriel Holder-Espinasse, MD,

Tracheal regeneration: Evidence of bone marrow mesenchymal stem cell involvement  Agathe Seguin, MD, PhD, Sonia Baccari, MD, Muriel Holder-Espinasse, MD,
Novel Tissue-Engineered Biodegradable Material for Reconstruction of Vascular Wall  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Satoshi Taketani, MD, Kei Torikai,

Novel Tissue-Engineered Biodegradable Material for Reconstruction of Vascular Wall  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Satoshi Taketani, MD, Kei Torikai,
Tissue-engineered stent-graft integrates with aortic wall by recruiting host tissue into graft scaffold  Mugiho Takeuchi, MD, Toru Kuratani, MD, PhD,

Tissue-engineered stent-graft integrates with aortic wall by recruiting host tissue into graft scaffold  Mugiho Takeuchi, MD, Toru Kuratani, MD, PhD,
Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 

Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 
Lucas P. Neff, MD, Bryan W. Tillman, MD, PhD, Saami K

Lucas P. Neff, MD, Bryan W. Tillman, MD, PhD, Saami K
Long-term biventricular support with rotary blood pumps in a patient with a noncontractile heart  Taichi Sakaguchi, MD, Shunsuke Saito, MD, Daisuke Yoshioka,

Long-term biventricular support with rotary blood pumps in a patient with a noncontractile heart  Taichi Sakaguchi, MD, Shunsuke Saito, MD, Daisuke Yoshioka,

Similar presentations

Ads by Google